MAGRO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 85
AS - Asia 70
EU - Europa 55
SA - Sud America 38
AF - Africa 4
Totale 252
Nazione #
US - Stati Uniti d'America 84
BR - Brasile 32
IT - Italia 28
SG - Singapore 26
VN - Vietnam 18
DE - Germania 12
CN - Cina 10
IN - India 6
AR - Argentina 4
BD - Bangladesh 4
GB - Regno Unito 4
FI - Finlandia 3
ID - Indonesia 3
EE - Estonia 2
NL - Olanda 2
PK - Pakistan 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AT - Austria 1
CA - Canada 1
CO - Colombia 1
EG - Egitto 1
JP - Giappone 1
KE - Kenya 1
PT - Portogallo 1
PY - Paraguay 1
Totale 252
Città #
Dallas 65
Singapore 16
Munich 11
Ho Chi Minh City 7
Bengaluru 5
Hanoi 5
Hefei 5
Milan 4
Santa Clara 4
Taranto 4
Adelfia 3
Ashburn 3
Asti 3
London 3
São Paulo 3
Assago 2
Beijing 2
Belo Horizonte 2
Biên Hòa 2
Haiphong 2
Johannesburg 2
Morciano di Leuca 2
Pelotas 2
Rome 2
San Juan Bautista 2
Saratov 2
Turku 2
Alexandria 1
Amritsar 1
Asunción 1
Bananal 1
Benevento 1
Boardman 1
Cabo Frio 1
Campo Mourão 1
Canguçu 1
Carney 1
Casca 1
Catu 1
Cianorte 1
Céu Azul 1
Denpasar 1
Dhaka 1
Dois Irmãos 1
Dourados 1
Helsinki 1
Hải Dương 1
Jardín América 1
Lahore 1
Los Angeles 1
Maragogipe 1
Marcionílio Souza 1
Medellín 1
Miraíma 1
Multan 1
Nairobi 1
Narsingdi 1
Newcastle upon Tyne 1
Nuremberg 1
Palmeira 1
Pekalongan 1
Pirpirituba 1
Riacho das Almas 1
Rio Grande da Serra 1
Rio de Janeiro 1
Salvador 1
San Jose 1
San Miguel de Tucumán 1
Santa Luzia 1
Sapucaia do Sul 1
São Sebastião do Caí 1
Thái Bình 1
Tokyo 1
Urânia 1
Viamão 1
Videira 1
Totale 214
Nome #
Microstructural alterations of the spinothalamic tract and neuropathic pain: A diffusion tensor imaging study in relapsing remitting multiple sclerosis 94
Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study 54
Fatigue in natalizumab-treated Multiple Sclerosis patients: How much is wearing-off to blame? 44
Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study 36
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic 29
Totale 257
Categoria #
all - tutte 1.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202418 0 12 2 0 1 0 0 0 0 0 2 1
2024/202554 3 0 3 0 6 7 4 1 4 3 7 16
2025/2026185 21 45 68 46 5 0 0 0 0 0 0 0
Totale 257